Landmark cancer trial shows success against ‘undruggable’ cancer — raising hopes for future treatments
Skip to main content
Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain<br>the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in<br>Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles<br>and JavaScript.
Advertisement
Bluesky
Access to this article via ICE Institution of Civil Engineers is not available.
Change institution
Buy or subscribe
The landmark success of a drug against an ‘undruggable’ cancer is spurring fresh optimism in the quest to treat seemingly untouchable tumour targets.
Access options
Access to this article via ICE Institution of Civil Engineers is not available.
Change institution
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
27,99 € / 30 days
cancel any time
Learn more
Subscribe to this journal
Receive 52 print issues and online access
199,00 € per year
only 3,83 € per issue
Learn more
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Learn more
Prices may be subject to local taxes which are calculated during checkout
doi: https://doi.org/10.1038/d41586-026-01760-w
References<br>O’Reilly, E. M. et al. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2605555 (2026).<br>Article<br>PubMed
Google Scholar
Pfaff, P. & Shokat, K. M. Biol. Chem. 407 , 91–103 (2026).<br>Article<br>PubMed
Google Scholar
Garralda, E. et al. Nature Med. 30 , 762–771 (2024).<br>Article<br>PubMed
Google Scholar
Dumbrava, E. E. et al. New Engl. J. Med. 394 , 872–883 (2026).<br>Article<br>PubMed
Google Scholar
Download references
Reprints and permissions
Related Articles
New drugs take aim at one of cancer’s deadliest mutations
Cancer drugs are closing in on some of the deadliest mutations
More than one-third of cancer cases are preventable, massive study finds
Cancer blood tests are everywhere — here's why you should be cautious
Subjects
Cancer
Drug discovery
Medical research
Latest on:
Cancer
Drug discovery
Medical research
Cancer Research UK bets on Manchester with £6-million funding boost
Career News 01 JUL 26
Steatosis shapes prognosis-defining liver metastasis heterogeneity in CRC
Article 01 JUL 26
Paper mill cancer studies get double the number of citations as genuine papers
News 01 JUL 26
Dual tumour–myeloid targeting of glioblastoma with GPNMB CAR-T cells
Article 01 JUL 26
Correcting congenital myasthenia-associated acetylcholine receptor defects
Article 01 JUL 26
AI systems devise hypotheses and ways to test them
News & Views 30 JUN 26
Vaccination elicits HIV broadly neutralizing antibodies in primates
Article 30 JUN 26
CRISPR’s next act: the companies editing the epigenome to treat disease
News Feature 26 JUN 26
A hidden predictor of sudden cardiac death uncovered by deep learning
News & Views 24 JUN 26
Jobs
Faculty Positions in Systems Hub, HKUST (GZ)
Tenure-track and tenured faculty positions at all ranks (Assistant Professor/Associate Professor/Professor)
Guangzhou, Guangdong (CN)
The Hong Kong University of Science and Technology (Guangzhou)
Associate/Senior Editor, BMC Sports Science, Medicine and Rehabilitation and BMC Rheumatology
You will contribute to the success of the BMC Series by supporting editorial handling of content in BMC Sports Science, Medicine and Rehabilitation an
New York City, New York (US)
Springer Nature Ltd
2 Junior Group Leader Positions
AI and Data Science for Bioengineering | Translational Pediatric Bioengineering
Barcelona (Localidad), Cataluña (ES)
Institute for Bioengineering of Catalonia (IBEC)
Professor / Associate Professor Positions at City University of Hong Kong (Dongguan)
The University invites individuals from diverse backgrounds to apply for faculty positions in this field
Dongguan, Guangdong, China
City University of Hong Kong (Dongguan)
Assistant Professor Positions at City University of Hong Kong (Dongguan)
The University invites individuals from diverse backgrounds to apply for faculty positions in this field
Dongguan, Guangdong, China
City University of Hong Kong (Dongguan)
Access to this article via ICE Institution of Civil Engineers is not available.
Change institution
Buy or subscribe
Related Articles
New drugs take aim at one of cancer’s deadliest mutations
Cancer drugs are closing in on some of the deadliest mutations
More than one-third of cancer cases are preventable, massive study finds
Cancer blood tests are everywhere — here's why you should be cautious
Subjects
Cancer
Drug discovery
Medical research
Sign up to Nature Briefing
An essential round-up of science news, opinion and analysis, delivered to your inbox every weekday.
Email address
Yes! Sign me up to receive the daily Nature Briefing email. I...